IMAS project wins Connecting Healthcare award The International Map of Axial Spondyloarthritis (IMAS) has been chosen as the winner of the Connecting Healthcare Award 2021 from more than 60 entries from across Europe from a range of collaborative projects. The Connecting Healthcare Award is an initiative of the European Federation of Pharmaceutical Industries and Associations…
The results of the first phase of REUMAVID have been presented at the British Society for Rheumatology Annual Conference (BSR 2021). The results of the first phase of the REUMAVID study were presented on Monday 14 April 2021 at the British Society for Rheumatology Annual Conference (BSR 2021). The interest in the study has led…
New paper on the impact of Axial Spondyloarthritis on patients’ working life in Europe The scientific manuscript “Patient-reported Impact of Axial Spondyloarthritis on Working Life: Results from the EMAS survey” has been accepted for publication in the journal Arthritis Care & Research. The research, which analyses data from the International Axial Spondyloarthritis Mapping Survey (EMAS),…
New article on gender differences in Axial Spondyloarthritis patients in Europe A new article from the IMAS project, entitled “Gender differences in Patient Journey to Diagnosis and Disease Outcomes: results from the European Map of Axial Spondyloarthritis (EMAS)” has been published in the journal Clinical Rheumatology. Historically, axSpA has been conceived as a predominantly male…
REUMAVID studio appears on Cypriot television After the Cypriot League Against Rheumatism (CYPLAR), the patient association leading the Cypriot part of the REUMAVID project, sent the first press release with the main findings of the REUMAVID study to the media, TV channels contacted them to interview them about the study and its objectives. Souzi Makri,…
More than 50% of Ankylosing Spondylitis patients have worsened health after lockdown Ankylosing spondylitis is a chronic immune-mediated inflammatory disease affecting the joints of the spine, the main symptom of which is inflammatory low back pain. Onset occurs between the ages of 20-30 years and up to 500,000 people in Spain suffer from the disease.…
The HTR-US Research Group is participating in the EULAR Annual European Rheumatology Congress (EULAR 2020 E-CONGRESS). EULAR (European Annual Congress of Rheumatology) has been taking place since 3 June and, due to the COVID-19 pandemic, is being held virtually. The aim of the EULAR European Congress of Rheumatology is to provide a forum, at the…
The Health & Territory Research (HTR) research group at the University of Seville is developing the REUMAVID survey (Evaluation of the Effects of the COVID-19 Pandemic on Rheumatic Patients in Spain), promoted by the Spanish Coordinator of Spondyloarthritis Associations (CEADE), in collaboration with the Galician Rheumatology League, the Catalan Rheumatology League, the Spanish Patients’…
HTR-US Research Group participated in EURECO supporting inclusive health for all 09/03/2020 On 5 and 6 March 2020 HTR had the opportunity to actively participate in the forum “EURECO Supporting Inclusive Health for All”, held in Brussels. This meeting was organised by the European Platform for Research on Inclusive Community Planning and Service Development…
The HTR-US Research Group will participate in the Annual Meeting. American College of Rheumatology 19/11/2019 The annual meeting of the American College of Rheumatology was held from November 8 to 13, 2019, in Atalanta, United States. The meeting allowed for the sharing of experiences among leading experts in rheumatology and provided opportunities for professional development,…
